Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours.
about
Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomesThe mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell deathNADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiformeLong-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice.HIF1/2α mediates hypoxia-induced LDHA expression in human pancreatic cancer cellsThe polymorphic and contradictory aspects of intermittent hypoxiaIntermittent hypoxia effect on osteoclastogenesis stimulated by neuroblastoma cells.Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells.Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study.Integrated 18F-fluorodeoxyglucose-positron emission tomography/dynamic contrast-enhanced computed tomography to phenotype non-small cell lung carcinomaThe clinicopathologic importance of serum lactic dehydrogenase in patients with gastric cancerIntermittent hypoxemia and OSA: implications for comorbidities.The Warburg effect: evolving interpretations of an established conceptReduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.Intermittent induction of HIF-1α produces lasting effects on malignant progression independent of its continued expression.Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma.Hypoxia-Inducible Factor-1α Expression in Indonesian Laryngeal Squamous Cell Carcinoma PatientsPutative Links Between Sleep Apnea and Cancer: From Hypotheses to Evolving Evidence.HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncologyThe hypoxia-mimetic agent CoCl₂ induces chemotherapy resistance in LOVO colorectal cancer cells.Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and womenMeasuring tumor cycling hypoxia and angiogenesis using a side-firing fiber optic probe.Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.Obstructive sleep apnea and cancer: Epidemiologic links and theoretical biological constructs.Multi-biomarker pattern for tumor identification and prognosis.Protons and Ca2+: ionic allies in tumor progression?Metabolic reprogramming of the tumor.HIF-mediated endothelial response during cancer progression.Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?PIM kinases: an overview in tumors and recent advances in pancreatic cancer.Obstructive sleep apnea and cancer: effects of intermittent hypoxia?Mechanisms of microglial activation in models of inflammation and hypoxia: Implications for chronic intermittent hypoxia.Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions.In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis.Pim-1 plays a pivotal role in hypoxia-induced chemoresistance.Macrophages, Inflammation, and Lung Cancer.Accelerated tumor growth under intermittent hypoxia is associated with hypoxia-inducible factor-1-dependent adaptive responses to hypoxia.Here come the sleep apnea-cancer studies.
P2860
Q24604279-02B7BFFA-0992-4411-9656-10FF412C143DQ27012559-B844BFAE-96CC-4D47-B35F-527EA64796C5Q28477083-BA924FC5-9BEC-4D34-AE21-D931846C50BCQ31029187-A224DA98-47D3-41E5-BCDB-AE552A97B7F8Q33648672-714287E5-CD7C-4552-BAFE-E6A59BE37DAAQ33913792-200F7C4D-4599-4FFA-BA2D-ED0974CB8BB8Q34078699-93EF0A3F-6825-4A71-AF59-5DE745D7DFECQ34170335-FF18582D-3183-41A6-BA03-87B885B1F155Q34276124-C9FE6659-569D-4B8A-AB58-177B2F7A43D9Q34410058-36369583-3D26-4DE7-82D3-82ED41C92732Q34534959-8A0842AE-00F9-44E0-8B79-50DF766CAC09Q34840423-120A2835-BA96-4FB0-9A6E-319C9C61787DQ35169587-4E1208B9-E109-48EB-A3CC-9D9A7BF2404FQ35247687-D74FC5D1-E87C-41CD-9551-EF990BEDAE25Q35499800-6103045A-C410-48C5-B96B-8A3A02A5A9C3Q36088193-8FA714FF-EF75-4B8B-BB9F-CB5810305BB0Q36203139-469DBFC5-F21E-47B7-88D6-9C13ACA81382Q36243213-ED9BD97E-D1E0-4F17-9829-5239DD5E1B03Q36413992-E768688B-FDEA-4625-905B-05D9F0E8B5B5Q36586203-106D9841-2A7F-435F-BA54-9DC085FC11CEQ36623935-ECD24EB6-EFF0-4511-8930-C49DFAB09371Q36761274-9780DDE2-1334-4C4D-9488-EF7E65CF3098Q36986320-2581D35D-1B5E-47E2-8DB0-23816BEA67A0Q37426436-18E617B1-886E-4328-885E-65CB00FA8A50Q37589156-7FCC14A7-B4B3-4610-A41F-AFF3EADCF323Q37731479-FF5B0750-13CF-47DD-85ED-F55533A21631Q37890322-7A075F01-48C8-4AD3-ADFC-4BD517D4185EQ37917316-286E6AC4-E75E-4C43-977F-C2AC63501A47Q37974518-1AA1BF05-21C8-433B-A105-60AA10723C52Q38007880-91693997-6A0E-4153-B4A9-9520FCABF648Q38081415-6591EB47-4326-4CD2-96EB-932E3939ABDAQ38209606-86734D0A-36DC-497B-A36C-D0D587961453Q38631730-03D05D0B-1232-43C5-B119-96EA25F13AC0Q38739054-D0C029D9-5E7F-481E-80B2-28E44E711675Q38937084-BCF37483-BAC2-4B4F-A550-DBB81D17ED7FQ39036069-DB634A23-C32D-41AC-BBD7-C2F376B55CA2Q39844632-66A48B59-0944-48C5-8A11-81B4731645ECQ41113415-8EBC4F79-258D-49C9-9345-1288588D62D4Q42365285-8D177420-65EB-4515-83FE-DFD989FB05DCQ42615870-129AD70E-FA55-40D2-A630-2CF8B722B7A4
P2860
Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intermittent hypoxia is a key ...... ial cell interplay in tumours.
@en
Intermittent hypoxia is a key ...... ial cell interplay in tumours.
@nl
type
label
Intermittent hypoxia is a key ...... ial cell interplay in tumours.
@en
Intermittent hypoxia is a key ...... ial cell interplay in tumours.
@nl
prefLabel
Intermittent hypoxia is a key ...... ial cell interplay in tumours.
@en
Intermittent hypoxia is a key ...... ial cell interplay in tumours.
@nl
P2860
P1433
P1476
Intermittent hypoxia is a key ...... ial cell interplay in tumours.
@en
P2093
P2860
P304
P356
10.1111/J.1742-4658.2008.06454.X
P407
P577
2008-04-25T00:00:00Z